RRM2 induces NF-kappaB-dependent MMP-9 activation and enhances cellular invasiveness.
about
Overexpression of RRM2 decreases thrombspondin-1 and increases VEGF production in human cancer cells in vitro and in vivo: implication of RRM2 in angiogenesisRibonucleotide reductase subunits M1 and M2 mRNA expression levels and clinical outcome of lung adenocarcinoma patients treated with docetaxel/gemcitabineSystemic therapies for pancreatic cancer--the role of pharmacogeneticsActivated protein C enhances cell motility of endothelial cells and MDA-MB-231 breast cancer cells by intracellular signal transduction.Metabolic genes in cancer: their roles in tumor progression and clinical implicationsCorrelation of chitinase 3-like 1 single nucleotide polymorphisms and haplotypes with uterine cervical cancer in Taiwanese women.Prognostic and therapeutic significance of ribonucleotide reductase small subunit M2 in estrogen-negative breast cancers.Reciprocal regulation of autophagy and dNTP pools in human cancer cells.High expression of ribonucleotide reductase subunit M2 correlates with poor prognosis of hepatocellular carcinoma.Relaxin induces matrix-metalloproteinases-9 and -13 via RXFP1: induction of MMP-9 involves the PI3K, ERK, Akt and PKC-ζ pathwaysRibonucleotide reductase small subunit M2B prognoses better survival in colorectal cancerClinical pharmacology and pharmacogenetics of gemcitabine.The expression of ribonucleotide reductase M2 in the carcinogenesis of uterine cervix and its relationship with clinicopathological characteristics and prognosis of cancer patients.Gene expression differences in adipose tissue associated with breast tumorigenesis.Ribonucleotide reductase subunit M2 predicts survival in subgroups of patients with non-small cell lung carcinoma: effects of gender and smoking statusHomo sapiens systemic RNA interference-defective-1 transmembrane family member 1 (SIDT1) protein mediates contact-dependent small RNA transfer and microRNA-21-driven chemoresistance.Systemic delivery of siRNA nanoparticles targeting RRM2 suppresses head and neck tumor growth.Emerging roles of the ribonucleotide reductase M2 in colorectal cancer and ultraviolet-induced DNA damage repair.Expression of Ribonucleotide Reductase Subunit-2 and Thymidylate Synthase Correlates with Poor Prognosis in Patients with Resected Stages I-III Non-Small Cell Lung Cancer.Ribonucleotide reductase small subunit M2 serves as a prognostic biomarker and predicts poor survival of colorectal cancers.Specificity protein (Sp) transcription factors Sp1, Sp3 and Sp4 are non-oncogene addiction genes in cancer cells.Identification of gene markers associated with aggressive meningioma by filtering across multiple sets of gene expression arrays.Increased expression of RRM2 by human papillomavirus E7 oncoprotein promotes angiogenesis in cervical cancerCREB1 directly activates the transcription of ribonucleotide reductase small subunit M2 and promotes the aggressiveness of human colorectal cancerTargeting ribonucleotide reductase for cancer therapy.Non-enzymatic action of RRM1 protein upregulates PTEN leading to inhibition of colorectal cancer metastasis.Precision Medicine and Pancreatic Cancer: A Gemcitabine Pathway Approach.Expression of RRM1 and RRM2 as a novel prognostic marker in advanced non-small cell lung cancer receiving chemotherapy.Riparsaponin isolated from Homonoia riparia Lour induces apoptosis of oral cancer cells.Downregulation of ribonucleotide reductase subunits M2 induces apoptosis and G1 arrest of cervical cancer cells.miR-211 regulates the expression of RRM2 in tumoral metastasis and recurrence in colorectal cancer patients with a k-ras gene mutation.Analysis of differentially expressed genes, clinical value and biological pathways in prostate cancer.Identification of key candidate genes and small molecule drugs in cervical cancer by bioinformatics strategy
P2860
Q21245720-15779CE4-CB42-459B-B207-87A3448A856FQ24652443-4B34CC14-44EE-4EB2-B619-3346E94AF067Q27021716-2F12008A-09C8-4559-8A67-77B5A19907A7Q33615455-726F009F-909D-4165-9D2B-7E719F6E2DA3Q33772469-E75C8DF8-B9E8-43D7-BB74-7C7CAD105821Q34155703-28EAD849-7F25-430E-84DF-C2BFEFCCFE4EQ34227409-EF2A893B-FF71-42E0-BA93-C8E1BD45F3D3Q34373116-63C56D45-0032-4F28-8FAE-E3FDCB0B2812Q34432197-A7BFC438-382B-43D6-BE10-5A751063A72DQ34640853-8892832B-5A65-419C-BCDE-D7E76727D1A5Q34899360-BC1A19A7-4010-4DCC-8DEE-5B670D50DC74Q34985979-FD29776A-BE56-4D94-8ED4-39875CCD4DCDQ35123132-1E15131B-7741-4745-B391-96C362D5FF3FQ35144489-32A4C120-C70B-4835-BC58-AF1508FEA01BQ35637007-0F1D160C-ED03-402B-9C3D-045BE13E8DBDQ35773897-BCA7AAA2-FB8C-423A-913E-8A4C09F55D5CQ35947017-7727F2C1-1EA9-44E9-88A6-0D6A00F00C43Q36233838-91323454-4EB4-41B6-A444-EE2BFA6D5F79Q36333164-A32D5E1F-A3CF-4D8E-A278-E1142330FF49Q36581114-2AEF1B01-6093-42B8-92E7-B203EE88B7B4Q37225520-F4F7A6B4-3C16-4997-9B40-15EAC795D292Q37341271-14C820AB-A43A-4670-A403-E3B0618E6243Q37594412-A6C9482A-E049-47BE-B782-EC751D73C606Q37718490-DF8A0902-D461-4A8F-AFC9-2820E90750BAQ38148222-DFFE4159-7610-4F43-862D-CD6F07AE5CF6Q38914638-D57D1A6B-CE5A-49FE-AFA0-BA75153C543FQ39283216-19CF85D2-3805-47C2-A365-F6CBE34E3130Q39327140-61C56BAE-4360-41BA-832D-1508CC1C86C7Q47106359-F3E39F38-E115-4976-B24F-A6151E8A4144Q52725569-401CBCEE-71DC-48A2-A9C7-BC45A23BDDD6Q54983378-9CBD8F4C-FB69-456E-9CB9-731C9D1A3252Q55004153-9277596C-A8E6-40D5-AA32-8C7A21BC9B3CQ57075019-AB67F8E2-D5F7-435F-8317-5C5DF3BC3B12
P2860
RRM2 induces NF-kappaB-dependent MMP-9 activation and enhances cellular invasiveness.
description
2006 nî lūn-bûn
@nan
2006 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
RRM2 induces NF-kappaB-dependent MMP-9 activation and enhances cellular invasiveness.
@ast
RRM2 induces NF-kappaB-dependent MMP-9 activation and enhances cellular invasiveness.
@en
RRM2 induces NF-kappaB-dependent MMP-9 activation and enhances cellular invasiveness.
@nl
type
label
RRM2 induces NF-kappaB-dependent MMP-9 activation and enhances cellular invasiveness.
@ast
RRM2 induces NF-kappaB-dependent MMP-9 activation and enhances cellular invasiveness.
@en
RRM2 induces NF-kappaB-dependent MMP-9 activation and enhances cellular invasiveness.
@nl
prefLabel
RRM2 induces NF-kappaB-dependent MMP-9 activation and enhances cellular invasiveness.
@ast
RRM2 induces NF-kappaB-dependent MMP-9 activation and enhances cellular invasiveness.
@en
RRM2 induces NF-kappaB-dependent MMP-9 activation and enhances cellular invasiveness.
@nl
P1476
RRM2 induces NF-kappaB-dependent MMP-9 activation and enhances cellular invasiveness.
@en
P2093
Edward E Whang
Mark S Duxbury
P304
P356
10.1016/J.BBRC.2006.12.177
P407
P577
2006-12-29T00:00:00Z